Zoetis announces that the U.S. Food and Drug Administration has approved Apoquel (oclacitinib), an oral therapy for the control of pruritus associated with allergic dermatitis and atopic dermatitis in dogs at least 12 months of age. Apoquel is a Janus kinase (JAK) inhibitor that targets the itch and inflammation pathway, providing fast-acting relief from itching and improving inflammation for dogs that suffer from allergic skin conditions.
100 Campus Drive Florham Park, NJ 07932
Tel: 1-888-963-8471